ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identifying a novel cuproptosis-related necroptosis gene subtype-related signature for predicting the prognosis, tumor microenvironment, and immunotherapy of hepatocellular carcinoma

Shi, Yuanxin; Qiu, Peng; Zhao, Kai; Li, Xiangyu; Feng, Yunxiang; Deng, Zhengdong*; Wang, Jianming*华中科技大学
Frontiers in Molecular Biosciences2023-5-23DOI: 10.3389/fmolb.2023.1165243
7阅读
引用收藏
分享

摘要

Background: Cuproptosis and necroptosis represent two distinct programmed cell death modalities implicated in neoplastic progression; however, the role of combining cuproptosis and necroptosis in hepatocellular carcinoma (HCC) remains to be elucidated.Methods: A total of 29 cuproptosis-related necroptosis genes (CRNGs) were identified, followed by an extensive analysis of their mutational characteristics, expression patterns, prognostic implications, and associations with the tumor microenvironment (TME). Subsequently, a CRNG subtype-related signature was developed, and its value of prognostic prediction, TME, and therapeutic responses in HCC were thoroughly investigated. Last, quantitative real-time PCR and Western blotting were employed for investigating the signature gene expression in 15 paired clinical tissue samples.Results: Two distinct CRNG subtypes were discerned, demonstrating associations between CRNG expression patterns, clinicopathological attributes, prognosis, and the TME. A CRNG subtype-related prognostic signature, subjected to external validation, was constructed, serving as an independent prognostic factor for HCC patients, indicating poor prognosis for high-risk individuals. Concurrently, the signature's correlations with an immune-suppressive TME, mutational features, stemness properties, immune checkpoint genes, chemoresistance-associated genes, and drug sensitivity were observed, signifying its utility in predicting treatment responses. Subsequently, highly accurate and clinically convenient nomograms were developed, and the signature genes were validated via quantitative real-time PCR and Western blotting, further substantiating the stability and dependability of the CRNG subtype-related prognostic signature.Conclusion: Overall, this investigation presented an extensive panorama of CRNGs and developed the CRNG subtype-related prognostic signature, which holds potential for implementation in personalized treatment strategies and prognostic forecasting for HCC patients.

学科与关键词

关键词
hepatocellular carcinomacuproptosisnecroptosisprognostic signaturetumor microenvironmentimmunotherapy
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Molecular Biosciences
发表日期
2023-05-23
卷期
第 10 卷
页码
1165243
DOI
10.3389/fmolb.2023.1165243
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81874062, 82072730]

作者

  • S

    Shi, Yuanxin (第一作者)

    huazhong univ sci & technol

  • Q

    Qiu, Peng

    huazhong univ sci & technol

查看全部 7 位作者收起作者
  • Z

    Zhao, Kai

    huazhong univ sci & technol

  • L

    Li, Xiangyu

    huazhong univ sci & technol

  • F

    Feng, Yunxiang

    huazhong univ sci & technol

  • D

    Deng, Zhengdong (通讯)

    huazhong univ sci & technol

  • W

    Wang, Jianming (通讯)

    huazhong univ sci & technol · wuhan univ sci & technol

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417